Literature DB >> 16585579

SUMOylation interferes with CCAAT/enhancer-binding protein beta-mediated c-myc repression, but not IL-4 activation in T cells.

Friederike Berberich-Siebelt1, Ingolf Berberich, Mindaugas Andrulis, Brigitte Santner-Nanan, Mithilesh K Jha, Stefan Klein-Hessling, Anneliese Schimpl, Edgar Serfling.   

Abstract

The transcription factor C/EBPbeta transactivates the IL-4 gene in murine T lymphocytes and facilitates Th2 cell responses. In this study, we demonstrate that C/EBPbeta also acts as a repressor of T cell proliferation. By binding to the c-myc promoter(s), C/EBPbeta represses c-Myc expression and, therefore, arrests T cells in the G1 phase of the cell cycle. For C/EBPbeta-mediated repression, the integrity of its N-terminal transactivation domain is essential whereas the central regulatory domain is dispensable. This central regulatory domain is sumoylated in vivo which leads to an alteration of the activity of C/EBPbeta. Whereas sumoylation does not affect the C/EBPbeta-mediated activation of the IL-4 gene, it relieves its repressive effect on c-Myc expression and T cell proliferation. Similar to several other transcription factors, sumoylation redistributes nuclear C/EBPbeta and targets it to pericentric heterochromatin. These results suggest an important role of sumoylation in adjusting the finely tuned balance between proliferation and differentiation in peripheral T cells which is controlled by C/EBPbeta.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585579     DOI: 10.4049/jimmunol.176.8.4843

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase.

Authors:  Arnab Nayak; Judith Glöckner-Pagel; Martin Vaeth; Julia E Schumann; Mathias Buttmann; Tobias Bopp; Edgar Schmitt; Edgar Serfling; Friederike Berberich-Siebelt
Journal:  J Biol Chem       Date:  2009-02-14       Impact factor: 5.157

Review 2.  CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.

Authors:  Yujie Liu; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

3.  Regulation of SIV mac 239 basal long terminal repeat activity and viral replication in macrophages: functional roles of two CCAAT/enhancer-binding protein beta sites in activation and interferon beta-mediated suppression.

Authors:  Shruthi Ravimohan; Lucio Gama; Sheila A Barber; Janice E Clements
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

4.  Crosstalk between phosphorylation and multi-site arginine/lysine methylation in C/EBPs.

Authors:  Achim Leutz; Ole Pless; Michael Lappe; Gunnar Dittmar; Elisabeth Kowenz-Leutz
Journal:  Transcription       Date:  2011 Jan-Feb

Review 5.  C/EBPß Isoform Specific Gene Regulation: It's a Lot more Complicated than you Think!

Authors:  Aaron J Spike; Jeffrey M Rosen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-02-20       Impact factor: 2.673

6.  The E3 ubiquitin ligase neuregulin receptor degradation protein 1 (Nrdp1) promotes M2 macrophage polarization by ubiquitinating and activating transcription factor CCAAT/enhancer-binding Protein β (C/EBPβ).

Authors:  Shuo Ye; Hongmei Xu; Jing Jin; Mingjin Yang; Chunmei Wang; Yizhi Yu; Xuetao Cao
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

Review 7.  CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.

Authors:  Cynthia A Zahnow
Journal:  Expert Rev Mol Med       Date:  2009-04-08       Impact factor: 5.600

8.  Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta.

Authors:  Nils Wethkamp; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

9.  Type I interferons regulate susceptibility to inflammation-induced preterm birth.

Authors:  Monica Cappelletti; Pietro Presicce; Matthew J Lawson; Vandana Chaturvedi; Traci E Stankiewicz; Simone Vanoni; Isaac Tw Harley; Jaclyn W McAlees; Daniel A Giles; Maria E Moreno-Fernandez; Cesar M Rueda; Paranth Senthamaraikannan; Xiaofei Sun; Rebekah Karns; Kasper Hoebe; Edith M Janssen; Christopher L Karp; David A Hildeman; Simon P Hogan; Suhas G Kallapur; Claire A Chougnet; Sing Sing Way; Senad Divanovic
Journal:  JCI Insight       Date:  2017-03-09

10.  C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpoint.

Authors:  R Ranjan; E A Thompson; K Yoon; R C Smart
Journal:  Oncogene       Date:  2009-07-06       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.